A pilot study of regenerative therapy using controlled release of recombinant human fibroblast growth factor for patients with pre-collapse osteonecrosis of the femoral head

被引：0
|
作者：
Yutaka Kuroda
Ryuta Asada
Kazutaka So
Atsushi Yonezawa
Manabu Nankaku
Kumi Mukai
Toshiko Ito-Ihara
Harue Tada
Michio Yamamoto
Toshinori Murayama
Satoshi Morita
Yasuhiko Tabata
Masayuki Yokode
Akira Shimizu
Shuichi Matsuda
Haruhiko Akiyama
机构：
[1] Kyoto University,Department of Orthopaedic Surgery, Graduate School of Medicine
[2] Gifu University Hospital,Clinical Research Center
[3] Kyoto University Hospital,Department of Clinical Pharmacology and Therapeutics
[4] Kyoto University Hospital,Rehabilitation Unit
[5] Kyoto University Hospital,Department of Clinical Innovative Medicine, Institute for Advancement of Clinical and Translational Research (iACT)
[6] Kyoto University Hospital,Department of Data Science, Institute for Advancement of Clinical and Translational Research (iACT)
[7] Kyoto University Hospital,Department of Experimental Therapeutics, Institute for Advancement of Clinical and Translational Research (iACT)
[8] Kyoto University,Department of Biomaterials, Field of Tissue Engineering, Institute for Frontier Medical Sciences
[9] Gifu University,Department of Orthopaedic Surgery
来源：
International Orthopaedics | 2016年 / 40卷
关键词：
Clinical trial; Femoral head; FGF; Growth factor; Osteonecrosis; Regenerative therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1747 / 1754
页数：7
相关论文
共 50 条
  • [21] The effect of recombinant human epidermal growth factor on radiation dermatitis in rectal and anal cancer patients: a self-controlled study
    Liu, Shuai
    Wang, Yun-Long
    Shi, Shu-Ting
    Zeng, Guang-Dong
    Song, Yi-Wen
    Zhang, Xiao-Dong
    Zheng, Jian
    Fan, Xin-Juan
    Liu, Yan-Ping
    BMC CANCER, 2022, 22 (01)
  • [22] The effect of recombinant human epidermal growth factor on radiation dermatitis in rectal and anal cancer patients: a self-controlled study
    Shuai Liu
    Yun-Long Wang
    Shu-Ting Shi
    Guang-Dong Zeng
    Yi-Wen Song
    Xiao-Dong Zhang
    Jian Zheng
    Xin-Juan Fan
    Yan-Ping Liu
    BMC Cancer, 22
  • [23] Effectiveness of a synthetic human recombinant epidermal growth factor in diabetic patients wound healing: Pilot, double-blind, randomized clinical controlled trial
    Oliveira, Bianca Campos
    Renaud Baptista de Oliveira, Beatriz Guitton
    Deutsch, Gabriela
    Pessanha, Fernanda Soares
    de Castilho, Selma Rodrigues
    WOUND REPAIR AND REGENERATION, 2021, 29 (06) : 920 - 926
  • [24] Periodontal Regenerative Therapy with Recombinant Human Fibroblast Growth Factor-2 and Deproteinized Bovine Bone Mineral in Patient with Chronic Periodontitis: An 18-month Follow-up Report
    Bizenjima, Takahiro
    Irokawa, Daisuke
    Tanaka, Kobun
    Saito, Atsushi
    Tomita, Sachiyo
    BULLETIN OF TOKYO DENTAL COLLEGE, 2021, 62 (02): : 107 - 117
  • [25] Local delivery of recombinant human bone morphogenetic proteins and bisphosphonate via sucrose acetate isobutyrate can prevent femoral head collapse in Legg-Calve-Perthes disease: a pilot study in pigs
    Tegan L. Cheng
    Ciara M. Murphy
    Laurence C. Cantrill
    Kathy Mikulec
    Clare Carpenter
    Aaron Schindeler
    David G. Little
    International Orthopaedics, 2014, 38 : 1527 - 1533
  • [26] Local delivery of recombinant human bone morphogenetic proteins and bisphosphonate via sucrose acetate isobutyrate can prevent femoral head collapse in Legg-Calve-Perthes disease: a pilot study in pigs
    Cheng, Tegan L.
    Murphy, Ciara M.
    Cantrill, Laurence C.
    Mikulec, Kathy
    Carpenter, Clare
    Schindeler, Aaron
    Little, David G.
    INTERNATIONAL ORTHOPAEDICS, 2014, 38 (07) : 1527 - 1533
  • [27] Ridge augmentation using recombinant human fibroblast growth factor-2 with biodegradable gelatin sponges incorporating -tricalcium phosphate: a preclinical study in dogs
    Hoshi, S.
    Akizuki, T.
    Matsuura, T.
    Ikawa, T.
    Kinoshita, A.
    Oda, S.
    Tabata, Y.
    Matsui, M.
    Izumi, Y.
    JOURNAL OF PERIODONTAL RESEARCH, 2016, 51 (01) : 77 - 85
  • [28] Efficacy and safety of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic venous ulcers: A pilot study
    Wieman, TJ
    WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE, 2003, 15 (08): : 257 - 264
  • [29] A Case Report of Periodontal Regenerative Therapy Using Recombinant Human Fibroblast Growth Factor 2 and Deproteinized Bovine Bone Mineral with Non-incised Papillae Surgical Approach (NIPSA) for Angular Bone Defect in Patient with Stage III Grade C Periodontitis
    Bizenjima, Takahiro
    Irokawa, Daisuke
    Yamada, Shigeko
    Saito, Atsushi
    Tomita, Sachiyo
    BULLETIN OF TOKYO DENTAL COLLEGE, 2023, 64 (04): : 145 - 155
  • [30] Minimal pre-operative leg length discrepancy as a risk factor of post-operative leg length discrepancy after total hip arthroplasty: a retrospective study of patients with non-traumatic osteonecrosis of the femoral head
    Hong Seok Kim
    Han Jin Lee
    Jeong Joon Yoo
    BMC Musculoskeletal Disorders, 24
12345